Recent Posts
- EpiVax Progresses on a Vaccine to Address SARS-CoV-2 Variants
- EpiVax Collaborates with Leidos on Malaria Vaccine Research, Series of Papers Published in Frontiers In Immunology
- Recipes for Success: Pilot
- Westin Immunogenicity Seminar, April 22, 2022
- EpiVax Licenses Tregitope Technology to Maruho Co., Ltd. for development of Tregitope-based Therapies to Treat Autoimmune Condition